Latest News

Mrs. Annette Widmann-Mauz (MdB), Minister of State and Tübingen CDU constituency representative, visited the WSIC for a roundtable discussion on the topic of the planned regional light rail system.For the largest infrastructure project in the Neckar-Alb region, the WSIC would have to change its current location.

The Preclinical Imaging and Radiopharmacy Department of the University Hospital Tübingen and ImaginAb, a global market leading biotech company, are cooperating in the field of cancer immunotherapy making Tübingen Europe's first center for the production of radiolabeled CD8 minibodies.

TheranosticValleySTR (STR= Research and Economic Region Stuttgart, Tübingen, Reutlingen) represents the concept for an innovative future cluster to fundamentally improve diagnosis and therapy of cancer, infectious and neurological diseases. The main drivers of this concept, the University of Tübingen, MPI Tübingen-Stuttgart and the NMI Reutlingen, are among the 15 chosen conceputal clusters (out of 117 applicants) to hand in a full concept. 

Ministers of the state of Baden-Württemberg announced the funding of the Biologicals Development Centre with the NMI in Reutlingen and the Werner Siemens Imaging Centre (WSIC) of the University and University Hospital of Tübingen as the responsible project promoters at the award ceremony for RegioWIN projects. The goal of the partners is to design, produce, functionalise and test biotechnologically produced proteins, so-called biologicals, in cooperation with academic groups and companies and to quickly bring them into use.

For people with a weakened immune system, invasive pulmonary aspergillosis, a fungal infection of the lungs, poses a great danger. In search of a new diagnostic method, the University Hospital of Tübingen has therefore joined forces with its scientific partners to investigate a new antibody-guided imaging method. The study is currently published in the renowned journal Nature Communications.